COMMON STI571: A BUDGET-FRIENDLY OPTION?

The emergence of common imatinib represents a substantial possibility for patients battling chronic myeloid leukemia and other conditions. Original brand-name imatinib, commonly known as Gleevec, carries a high price label, frequently causing accessibility for some individuals. Off-brand versions